News & Updates

Obesity, diabetes, family history up prostate cancer risk in IBD patients
Obesity, diabetes, family history up prostate cancer risk in IBD patients
10 Feb 2022 byStephen Padilla

A longitudinal national database study of patients with inflammatory bowel disease (IBD) has identified several risk factors for the development of prostate cancer (PC), including age, obesity, diabetes, married status, family history of PC, and African American race.

Obesity, diabetes, family history up prostate cancer risk in IBD patients
10 Feb 2022
Aspirin boosts survival in multiple myeloma
Aspirin boosts survival in multiple myeloma
09 Feb 2022

Multiple myeloma patients who use aspirin regularly show a survival advantage over their counterparts who do not use said agent, a study has found.

Aspirin boosts survival in multiple myeloma
09 Feb 2022
Adherence to lenalidomide deficient in multiple myeloma patients
Adherence to lenalidomide deficient in multiple myeloma patients
07 Feb 2022
Obese breast cancer patients on T-DM1 prone to more treatment adjustments
Obese breast cancer patients on T-DM1 prone to more treatment adjustments
04 Feb 2022

More treatment modifications secondary to adverse events appear necessary among obese patients receiving ado-trastuzumab emtansine (T-DM1), an antibody-drug conjugate indicated for the treatment of HER2-positive breast cancer, relative to nonobese counterparts, reports a study.

Obese breast cancer patients on T-DM1 prone to more treatment adjustments
04 Feb 2022
Risk of colorectal cancer mortality after adenoma removal differs by sex
Risk of colorectal cancer mortality after adenoma removal differs by sex
02 Feb 2022

Women appear to be at higher risk of colorectal cancer death following adenoma removal, whereas men are at lower risk, as reported in a recent study.

Risk of colorectal cancer mortality after adenoma removal differs by sex
02 Feb 2022